Results 171 to 180 of about 7,176 (216)

CONJUGATED ESTROGENS AND FIBROCYSTIC BREAST DISEASE

American Journal of Epidemiology, 1986
The association between replacement estrogen use and subsequent development of fibrocystic breast disease was studied at Group Health Cooperative of Puget Sound. Included were 142 women aged 50-64 years diagnosed by biopsy as having fibrocystic breast disease during the years 1978 through 1983.
S S, Jick, A M, Walker, H, Jick
openaire   +2 more sources

Fibrocystic disease of the breast.

The Journal of reproductive medicine, 1979
Fibrocystic disease is the most common type of lesion in the female breast. It is a common dumping ground for a variety of distinct clinical and histologic entities which require different modalities of therapy and which have different malignant transformation potentials.
H P, Leis, C S, Kwon
openaire   +1 more source

Thyroid hormones in fibrocystic breast disease

European Journal of Endocrinology, 1995
Martinez L, Castilla JA, Gil T, Molina J, Alarcón JL, Marcos C, Herruzo A. Thyroid hormones in fibrocystic breast disease. Eur J Endocrinol 1995;132:673–6. ISSN 0804–4643 This study was undertaken to evaluate the role of thyroid hormones in fibrocystic breast disease. The concentrations of thyroid-stimulating hormone (TSH), thyroxine (T4), free
Martínez, Luis, Castilla, José Antonio, Gil Ruiz, María Teresa, Molina, Jorge, Alarcón, José Luis, Marcos, Cristina, Herruzo, Alfonso J.   +6 more
openaire   +3 more sources

Fibrocystic Breast Disease

Plastic Surgical Nursing, 1993
Fibrocystic breast disease refers to a constellation of breast changes observed in premenopausal women, and 90% of all women experience evidence of pathophysiologic changes in the breast during their lifetime. Although most breast changes are harmless, women need to be concerned with the increased risk of breast cancer, one of the leading causes of ...
openaire   +2 more sources

Trace element content in breasts with fibrocystic disease

Biological Trace Element Research, 1994
The trace elements antimony, bromine, cesium, cobalt, iron, rubidium, scandium, strontium and zinc were determined by instrumental neutron activation analysis in breast tissue samples with fibrocystic disease and in samples with fibroadenoma tumors. The histological lesions of each breast sample with fibrocystic disease were recorded, and a statistical
G D, Kanias, E, Kouri, H, Arvaniti, H, Karaiosifidi, S, Kouneli   +4 more
openaire   +2 more sources

Fibrocystic Breast Disease An Update and Review

Journal of Obstetric, Gynecologic & Neonatal Nursing, 1990
Fibrocystic breast disease (FBD) is a benign condition that afflicts at least 50% of women of childbearing age. Because of the occurrence rate, the condition is sometimes referred to as a nondisease. The cause of FBD remains unknown, and treatment is only empirical.
openaire   +2 more sources

Fibrocystic breast disease.

American family physician, 1987
Fibrocystic breast disease is characterized by breast pain, lumpiness or cysts. The few patients who have atypia on breast biopsy are at substantially increased risk for the development of breast cancer. Management of fibrocystic breast disease involves monitoring for breast cancer by repeated physical and mammographic examinations.
openaire   +1 more source

Subcutaneous Mastectomy and Fibrocystic Disease of the Breast

Clinics in Plastic Surgery, 1976
There has been a considerable amount of data presented to implicate moderate to severe fibrocystic disease as a strong precursor of breast cancer. When a premenopausal woman with nodular breasts presents a biopsy examination characterized by sclerosing adenosis, intraductal hyperplasia and/or papillomatosis, microcystic disease, macrocystic disease, or
openaire   +2 more sources

Fibrocystic Disease of the Breast

International Journal of Dermatology, 1985
P A, Coombs, J C, Allegra
openaire   +2 more sources

Polycystic Ovary Syndrome and Fibrocystic Breast Disease: An Updated Review

Hormone and Metabolic Research, 2021
Michał Kunicki, Roman Smolarczyk
exaly